US Representative

Richard Hudson Authored & Sponsored Legislation

Session

Cosponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1004

Introduced
2/5/25  
Refer
2/5/25  
Love Lives On Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1083

Introduced
2/6/25  
Incentivizing Readiness and Environmental Protection Integration Sales Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1195

Introduced
2/11/25  
Protect Medicaid Act This bill prohibits federal payment under Medicaid for the administrative costs of providing health benefits to noncitizens who are ineligible for Medicaid based on their immigration status. The Department of Health and Human Services must report on specified information regarding states that provide health benefits to such individuals.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1458

Introduced
2/21/25  
Refer
2/21/25  
VETS Opportunity Act of 2025 Veterans Education and Technical Skills Opportunity Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1476

Introduced
2/21/25  
PLASMA Act Preserving Life-saving Access to Specialty Medicines in America Act

Original Cosponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1041

Introduced
2/6/25  
Refer
2/6/25  
Report Pass
5/19/25  
Veterans 2nd Amendment Protection Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1078

Introduced
2/6/25  
Respect State Housing Laws Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1181

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1200

Introduced
2/11/25  
Freight RAILCAR Act of 2025 Freight Rail Assets Investment to Launch Commercial Activity Revitalization Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1492

Introduced
2/21/25  
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.